Lemaitre Vascular (LMAT) Deferred Taxes (2010 - 2013)
Lemaitre Vascular's (LMAT) quarterly Deferred Taxes came in at $2.0 million in Q4 2013, up 48775.0% quarter-over-quarter from $4000.0 in Q1 2012.
Powered by 
Analysis
Lemaitre Vascular (LMAT) Deferred Taxes (2010 - 2013) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Deferred Taxes for 3 consecutive years, with $2.0 million the latest figure, recorded in Q4 2013.
- On a quarterly basis, Deferred Taxes changed N/A year-over-year to $2.0 million in Q4 2013; TTM through Dec 2013 was -$561000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $2.3 million, up 612.64% from the prior year.
- Deferred Taxes was $2.0 million for Q4 2013 at Lemaitre Vascular, up from $4000.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $2.0 million in Q4 2013 and troughed at -$2.6 million in Q4 2010.
- A 3-year average of -$140250.0 and a median of $49000.0 in 2010 frame the typical range for Deferred Taxes.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | -31.00 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 127.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 107.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 17.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | -181.30 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | -300,000.00 |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 600,000.00 |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2013 | 1.96 Mn |
| Mar 31, 2012 | 4,000.00 |
| Dec 31, 2010 | -2.61 Mn |
| Sep 30, 2010 | 94,000.00 |